Table 2.

Methods for carbapenemase identification.

Carbapenemase screening methods 500 (18.5)	Methods for carbapenemase identification 2,692 (99.5)	Molecular methods 1712 (63.6)	Immunochromatography 887 (32.9)
Type n (%)	Type n (%)	Type n (%)	Type n (%)
mCIM 409 (81.8) mHT 50 (10) Colorimetric 41 (8.2)	Molecular 1,571 (58.4) IC 804 (29.8) Sinergy-inhibitors 168 (6.2) IC + Molecular 72 (2.7) Molecular+S-I 66 (2.5) IC + Sinergy-inhibitors 8 (0.3) IC + Molecular+S-I 3 (0.1)	PCR in-house 578 (33.8) GeneXpert Cepheid 577 (33.7) OXVIKPND PCR assay (Progenie) 150 (8.8) PCR Allplex Entero DR assay (Seegene) 122 (7.1) EAZYPLEX 62 (3.6) PCR BD MAX Xheck-points CPO 50 (2.9) NanoSphere/Verigene 47 (2.7) PCR CNM-Carlos III 39 (2.3) Genie II Optigene 26 (1.5) Whole genome sequencing (Illumina) 23 (1.3) Sanger Sequencing 18 (1.1) PCR AMR (AB analitica) 12 (0.7) PCR HAIN 7 (0.4) PCR ELITECH carbas 1 (0.1)	NG Biotech (NG Test Carba-5) 381 (43) OXA-48 KSeT (CORIS Bioconcept) 211 (23.8) O.K.N.V.I RESIST5 (CORIS Bioconcept) 100 (11.3) LETI-TEST 89 (10) CORIS Bioconcept 66 (7.4) Resist-3 OKN KSeT (CORIS Bioconcept) 40 (4.5)

mCIM, Modified carbapenem inactivation method; mHT, modified Hodge Test; IC, Immunochromatography; S-I, Sinergy-inhibitors.